BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abenavoli L, Milic N, Luzza F, Boccuto L, De Lorenzo A. Polyphenols Treatment in Patients with Nonalcoholic Fatty Liver Disease. J Transl Int Med. 2017;5:144-147. [PMID: 29164049 DOI: 10.1515/jtim-2017-0027] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Panera N, Barbaro B, Della Corte C, Mosca A, Nobili V, Alisi A. A review of the pathogenic and therapeutic role of nutrition in pediatric nonalcoholic fatty liver disease. Nutrition Research 2018;58:1-16. [DOI: 10.1016/j.nutres.2018.05.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
2 Cha SH, Hwang Y, Heo SJ, Jun HS. Diphlorethohydroxycarmalol Attenuates Palmitate-Induced Hepatic Lipogenesis and Inflammation. Mar Drugs 2020;18:E475. [PMID: 32962167 DOI: 10.3390/md18090475] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Bayram HM, Majoo FM, Ozturkcan A. Polyphenols in the prevention and treatment of non-alcoholic fatty liver disease: An update of preclinical and clinical studies. Clin Nutr ESPEN 2021;44:1-14. [PMID: 34330452 DOI: 10.1016/j.clnesp.2021.06.026] [Reference Citation Analysis]
4 Wang JB, Gu Y, Zhang MX, Yang S, Wang Y, Wang W, Li XR, Zhao YT, Wang HT. High expression of type I inositol 1,4,5-trisphosphate receptor in the kidney of rats with hepatorenal syndrome. World J Gastroenterol 2018; 24(29): 3273-3280 [PMID: 30090007 DOI: 10.3748/wjg.v24.i29.3273] [Reference Citation Analysis]
5 Liu YT, Lai YH, Lin HH, Chen JH. Lotus Seedpod Extracts Reduced Lipid Accumulation and Lipotoxicity in Hepatocytes. Nutrients 2019;11:E2895. [PMID: 31795130 DOI: 10.3390/nu11122895] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
6 Gosal H, Kaur H, Chakwop Ngassa H, Elmenawi KA, Anil V, Mohammed L. The Significance of the Mediterranean Diet in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review. Cureus 2021;13:e15618. [PMID: 34277236 DOI: 10.7759/cureus.15618] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Abou Assi R, Abdulbaqi IM, Siok Yee C. The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update. Pharmaceuticals (Basel) 2021;14:215. [PMID: 33806527 DOI: 10.3390/ph14030215] [Reference Citation Analysis]
8 Abenavoli L, Larussa T, Corea A, Procopio AC, Boccuto L, Dallio M, Federico A, Luzza F. Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease. Nutrients 2021;13:494. [PMID: 33546130 DOI: 10.3390/nu13020494] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Fliss-Isakov N, Kariv R, Webb M, Ivancovsky D, Margalit D, Zelber-Sagi S. Mediterranean dietary components are inversely associated with advanced colorectal polyps: A case-control study. World J Gastroenterol 2018; 24(24): 2617-2627 [PMID: 29962818 DOI: 10.3748/wjg.v24.i24.2617] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
10 Yang JP, Shin JH, Seo SH, Kim SG, Lee SH, Shin EH. Effects of Antioxidants in Reducing Accumulation of Fat in Hepatocyte. Int J Mol Sci 2018;19:E2563. [PMID: 30158441 DOI: 10.3390/ijms19092563] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
11 Šlosár M, Kopta T, Hegedűs O, Hegedűsová A, Mezeyová I, Timoracká M, Mezey J. Yield parameters, antioxidant activity, polyphenol and total soluble solids content of beetroot cultivars with different flesh colours. Folia Horticulturae 2020;32:351-62. [DOI: 10.2478/fhort-2020-0030] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Abenavoli L, Boccuto L, Federico A, Dallio M, Loguercio C, Di Renzo L, De Lorenzo A. Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way. Int J Environ Res Public Health. 2019;16. [PMID: 31438482 DOI: 10.3390/ijerph16173011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 13.0] [Reference Citation Analysis]
13 Fotschki B, Juśkiewicz J, Jurgoński A, Sójka M. Fructo-Oligosaccharides and Pectins Enhance Beneficial Effects of Raspberry Polyphenols in Rats with Nonalcoholic Fatty Liver. Nutrients 2021;13:833. [PMID: 33802455 DOI: 10.3390/nu13030833] [Reference Citation Analysis]
14 Ji Y, Yin Y, Li Z, Zhang W. Gut Microbiota-Derived Components and Metabolites in the Progression of Non-Alcoholic Fatty Liver Disease (NAFLD). Nutrients. 2019;11. [PMID: 31349604 DOI: 10.3390/nu11081712] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 10.3] [Reference Citation Analysis]
15 Colica C, Milanović M, Milić N, Aiello V, De Lorenzo A, Abenavoli L. A Systematic Review on Natural Antioxidant Properties of Resveratrol. Natural Product Communications 2018;13:1934578X1801300. [DOI: 10.1177/1934578x1801300923] [Cited by in Crossref: 7] [Article Influence: 1.8] [Reference Citation Analysis]
16 Parafati M, Lascala A, La Russa D, Mignogna C, Trimboli F, Morittu VM, Riillo C, Macirella R, Mollace V, Brunelli E, Janda E. Bergamot Polyphenols Boost Therapeutic Effects of the Diet on Non-Alcoholic Steatohepatitis (NASH) Induced by "Junk Food": Evidence for Anti-Inflammatory Activity. Nutrients 2018;10:E1604. [PMID: 30388763 DOI: 10.3390/nu10111604] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
17 Nikkhah-bodaghi M, Ghanavati M, Hekmatdoost A. Polyphenol intakes and risk of impaired lipid profile, elevated hepatic enzymes and nonalcoholic fatty liver disease. NFS 2019;49:903-10. [DOI: 10.1108/nfs-12-2018-0338] [Cited by in Crossref: 7] [Article Influence: 2.3] [Reference Citation Analysis]
18 Abenavoli L, Scarpellini E, Pellicano R, Fagoonee S, Larussa T, Luzza F. Mediterranean diet and probiotics supplementation to treat non-alcoholic fatty liver disease. Minerva Med 2020;111:526-8. [PMID: 33140925 DOI: 10.23736/S0026-4806.20.07089-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Berk K, Drygalski K, Harasim-symbor E, Charytoniuk T, Iłowska N, Łukaszuk B, Chabowski A, Konstantynowicz-nowicka K. The effect of enterolactone on liver lipid precursors of inflammation. Life Sciences 2019;221:341-7. [DOI: 10.1016/j.lfs.2019.02.044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
20 Lima Júnior JP, Franco RR, Saraiva AL, Moraes IB, Espindola FS. Anacardium humile St. Hil as a novel source of antioxidant, antiglycation and α-amylase inhibitors molecules with potential for management of oxidative stress and diabetes. J Ethnopharmacol 2021;268:113667. [PMID: 33301920 DOI: 10.1016/j.jep.2020.113667] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Abenavoli L, Di Renzo L, Boccuto L, Alwardat N, Gratteri S, De Lorenzo A. Health benefits of Mediterranean diet in nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol. 2018;12:873-881. [PMID: 30033779 DOI: 10.1080/17474124.2018.1503947] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
22 Magaña-cerino JM, Tiessen A, Soto-luna IC, Peniche-pavía HA, Vargas-guerrero B, Domínguez-rosales JA, García-lópez PM, Gurrola-díaz CM. Consumption of nixtamal from a new variety of hybrid blue maize ameliorates liver oxidative stress and inflammation in a high-fat diet rat model. Journal of Functional Foods 2020;72:104075. [DOI: 10.1016/j.jff.2020.104075] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
23 Khalatbari-Soltani S, Marques-Vidal P, Imamura F, Forouhi NG. Prospective association between adherence to the Mediterranean diet and hepatic steatosis: the Swiss CoLaus cohort study. BMJ Open 2020;10:e040959. [PMID: 33371031 DOI: 10.1136/bmjopen-2020-040959] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Naeini F, Namkhah Z, Ostadrahimi A, Tutunchi H, Hosseinzadeh-Attar MJ. A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease. Adv Nutr 2021;12:413-28. [PMID: 32879962 DOI: 10.1093/advances/nmaa106] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]